Thomas P. Ahern

3.4k total citations
108 papers, 2.5k citations indexed

About

Thomas P. Ahern is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Thomas P. Ahern has authored 108 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 37 papers in Cancer Research and 34 papers in Genetics. Recurrent topics in Thomas P. Ahern's work include Estrogen and related hormone effects (29 papers), Breast Cancer Treatment Studies (17 papers) and Cancer Risks and Factors (15 papers). Thomas P. Ahern is often cited by papers focused on Estrogen and related hormone effects (29 papers), Breast Cancer Treatment Studies (17 papers) and Cancer Risks and Factors (15 papers). Thomas P. Ahern collaborates with scholars based in United States, Denmark and Sweden. Thomas P. Ahern's co-authors include Timothy L. Lash, Deirdre Cronin‐Fenton, Henrik Toft Sørensen, Lars Pedersen, Per Damkier, Rebecca A. Silliman, Peer Christiansen, Jens Peter Garne, T. L. Lash and Signe Borgquist and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Thomas P. Ahern

98 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas P. Ahern United States 28 913 641 596 494 461 108 2.5k
Elizabeth M. Poole United States 36 582 0.6× 1.3k 2.0× 246 0.4× 354 0.7× 835 1.8× 134 3.6k
J. K. McLaughlin United States 33 467 0.5× 899 1.4× 1.5k 2.5× 317 0.6× 472 1.0× 58 4.1k
Susan M. Farrington United Kingdom 39 1.0k 1.1× 1.6k 2.6× 447 0.8× 854 1.7× 1.4k 3.0× 102 4.6k
Chen Yuan China 31 540 0.6× 851 1.3× 709 1.2× 126 0.3× 930 2.0× 121 3.3k
Therese B. Bevers United States 28 1.0k 1.1× 1.8k 2.8× 277 0.5× 1.3k 2.6× 584 1.3× 117 3.9k
Katherine D. Crew United States 36 813 0.9× 2.8k 4.4× 1.1k 1.8× 1.0k 2.1× 1.1k 2.4× 181 6.0k
Marc L. Citron United States 30 943 1.0× 1.3k 2.0× 327 0.5× 241 0.5× 778 1.7× 66 3.6k
Ernst A. Lien Norway 37 646 0.7× 1.3k 2.0× 239 0.4× 2.0k 4.1× 930 2.0× 81 4.1k
Darcy Spicer United States 29 813 0.9× 2.0k 3.2× 163 0.3× 846 1.7× 880 1.9× 91 3.8k
Sarah Parish United Kingdom 33 358 0.4× 110 0.2× 1.4k 2.3× 441 0.9× 528 1.1× 84 3.9k

Countries citing papers authored by Thomas P. Ahern

Since Specialization
Citations

This map shows the geographic impact of Thomas P. Ahern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas P. Ahern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas P. Ahern more than expected).

Fields of papers citing papers by Thomas P. Ahern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas P. Ahern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas P. Ahern. The network helps show where Thomas P. Ahern may publish in the future.

Co-authorship network of co-authors of Thomas P. Ahern

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas P. Ahern. A scholar is included among the top collaborators of Thomas P. Ahern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas P. Ahern. Thomas P. Ahern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pedersen, Rikke Neess, Mette Nørgaard, Lene Mellemkjær, et al.. (2025). Association between low-dose aspirin use and breast cancer recurrence: a Danish nationwide cohort study with up to 23 years of follow-up. British Journal of Cancer. 133(6). 865–873.
3.
Ahern, Thomas P., James W. Baurley, Maret L. Maliniak, et al.. (2025). Genetic variants in tamoxifen metabolism and early treatment discontinuation among premenopausal breast cancer patients. Breast Cancer Research and Treatment. 212(2). 251–260. 1 indexed citations
4.
MacLehose, Richard F., et al.. (2024). Nondifferential misclassification of outcome under (near-) perfect specificity: a simulation study. American Journal of Epidemiology. 194(6). 1668–1672. 1 indexed citations
6.
Collin, Lindsay J., Lance A. Waller, Deirdre Cronin‐Fenton, et al.. (2024). The Population-level Effect of Adjuvant Therapies on Breast Cancer Recurrence: Application of the Trend-in-Trend Design. Epidemiology. 35(5). 660–666. 1 indexed citations
7.
Hjorth, Cathrine F., Per Damkier, Tore Bjerregaard Stage, et al.. (2022). Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark. Breast Cancer Research and Treatment. 194(2). 353–363. 5 indexed citations
8.
Ahern, Thomas P., et al.. (2021). Lifestyle, Behavioral, and Dietary Risk Factors in Relation to Mammographic Breast Density in Women at High Risk for Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 30(5). 936–944. 4 indexed citations
9.
Collin, Lindsay J., Deirdre Cronin‐Fenton, Thomas P. Ahern, et al.. (2021). Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal Women. Clinical Cancer Research. 27(5). 1421–1428. 33 indexed citations
10.
Villanti, Andrea C., Elias M. Klemperer, Brian L. Sprague, & Thomas P. Ahern. (2021). State-level rurality and cigarette smoking-associated cancer incidence and mortality: Do individual-level trends translate to population-level outcomes?. Preventive Medicine. 152(Pt 2). 106759–106759. 6 indexed citations
11.
Ahern, Thomas P., Lindsay J. Collin, James W. Baurley, et al.. (2020). Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer Patients. Cancer Epidemiology Biomarkers & Prevention. 29(3). 582–590. 7 indexed citations
12.
Collin, Lindsay J., Anders H. Riis, Richard F. MacLehose, et al.. (2020). <p>Application of the Adaptive Validation Substudy Design to Colorectal Cancer Recurrence</p>. Clinical Epidemiology. Volume 12. 113–121. 1 indexed citations
13.
Ahern, Thomas P., et al.. (2019). Prescription patterns before, during and after pregnancy among Dutch women:A drug utilization study. University of Groningen research database (University of Groningen / Centre for Information Technology). 8 indexed citations
14.
Broe, Anne, Anton Pottegård, Jesper Hallas, et al.. (2019). Phthalate exposure from drugs during pregnancy and possible risk of preterm birth and small for gestational age. European Journal of Obstetrics & Gynecology and Reproductive Biology. 240. 293–299. 27 indexed citations
15.
Ahern, Thomas P., et al.. (2018). Postoperative opioid prescribing patterns and use after vascular surgery. Vascular Medicine. 24(1). 63–69. 21 indexed citations
16.
Collin, Lindsay J., Deirdre Cronin‐Fenton, Thomas P. Ahern, et al.. (2018). Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark. BMJ Open. 8(7). e021805–e021805. 18 indexed citations
17.
Beynnon, Bruce D., Thomas P. Ahern, Peter A. Holoch, et al.. (2018). Post-Discharge Opioid Prescribing and Use after Common Surgical Procedure. Journal of the American College of Surgeons. 226(6). 1004–1012. 143 indexed citations
18.
Ahern, Thomas P., Brian L. Sprague, Michael C. S. Bissell, et al.. (2017). Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population. Cancer Epidemiology Biomarkers & Prevention. 26(6). 938–944. 28 indexed citations
19.
Cronin‐Fenton, Deirdre, Uffe Heide‐Jørgensen, Thomas P. Ahern, et al.. (2016). Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence. Epidemiology. 27(4). 586–593. 28 indexed citations
20.
Lash, Timothy L. & Thomas P. Ahern. (2012). Bias Analysis to Guide New Data Collection. The International Journal of Biostatistics. 8(2). 1–23. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026